Nitric Oxide Donors Induce Neurotrophin-Like Survival Signaling and Protect Neurons against Apoptosis

Molecular Pharmacology

Volumn 68, Issue 4, 2005, Pages 1006-1017

  Culmsee, Carsten ^a,b   Gerling, Norbert ^a   Landshamer, Stefan ^f   Rickerts, Bianca ^c   Duchstein, Hans Jürgen ^c   Umezawa, Kazuo ^d   Klumpp, Susanne ^e   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d KEIO UNIVERSITY   (Japan)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f Ludwig Maximilians Universität ^*

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 O METHYLETHYL 3,4 DEPHOSTATIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; ETHYL 3,4 DEPHOSTATIN; GUANYLATE CYCLASE INHIBITOR; KT 5823; METHOXIME 3,4 DEPHOSTATIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N ACETYL S NITROSOPENICILLAMINE; NERVE GROWTH FACTOR; NEUROTROPHIN; NITRIC OXIDE DONOR; NITROSAMINE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; STAUROSPORINE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARBAZOLES; CELL SURVIVAL; CYCLIC GMP; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MAP KINASE SIGNALING SYSTEM; NERVE GROWTH FACTOR; NEURONS; NITRIC OXIDE DONORS; PENICILLAMINE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 25144442366     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.105.013086     Document Type: Article

References (72)

1. Ahern GP, Klyachko VA, and Jackson MB (2002) cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci 25:510-517.
2. Alderton WK, Cooper CE, and Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593-615.
3. Brunet A, Datta SR, and Greenberg ME (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297-305.
4. Buckley DA, Cheng A, Kiely PA, Tremblay ML, and O'Connor R (2002) Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts. Mol Cell Biol 22:1998-2010.
5. Callsen D, Sandau KB, and Bruene B (1999) Nitric oxide and superoxide inhibit platelet-derived growth factor receptor phosphotyrosine phosphatases. Free Radic Biol Med 26:1544-1553.
6. Caselli A, Camici G, Manao G, Moneti G, Pazzagli L, Cappugi G, and Ramponi G (1994) Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. J Biol Chem 269:24878-24882.
7. Caselli A, Chiarugi P, Camici G, Manao G, and Ramponi G (1995) In vivo inactivation of phosphotyrosine protein phosphatases by nitric oxide. FEBS Lett 374:249-252.
8. Cheng A, Wang S, Cai J, Rao MS, and Mattson MP (2003) Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol 258:319-333.
9. Ciani E, Guidi S, Della Valle G, Perini G, Bartesaghi R, and Contestabile A (2002) Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation. J Biol Chem 277:49896-49902.
10. Contestabile A and Ciani E (2004) Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation. Neurochem Int 45:903-914.
11. Crowder RJ and Freeman RS (1998) Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factordependent sympathetic neurons. J Neurosci 18:2933-2943.
12. Culmsee C, Gerling N, Lehmann M, Nikolova-Karakashian M, Prehn JH, Mattson MP, and Krieglstein J (2002) Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TrkA and requires the common neurotrophin receptor p75. Neurosci 115:1089-1108.
13. Davis KL, Martin E, Turko IV, and Murad F (2001) Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203-236.
14. Dawson TM, Dawson VL, and Snyder SH (1992) A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 32:297-311.
15. Eliasson MJL, Huang Z, Ferrantre Z, Sasamata M, Molliver ME, Snyder SH, and Moskowitz MA (1999) Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci 19:5910-5918.
16. Endres M, Laufs U, Huang Z, Nakamura T, Hunag P, Moskowitz MA, and Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:8880-8885.
17. Farinelli SE, Park DS, and Greene LA (1996) Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J Neurosci 16:2325-2334.
18. Figiel I and Kaczmarek L (1997) Orthovanadate induces cell death in rat dentate gyrus primary culture. Neuroreport 8:2465-2470.
19. Figueroa S, Lopez E, Arce C, Oset-Gasque MJ, and Gonzalez MP (2005) SNAP, a NO donor, induces cellular protection only when cortical neurons are submitted to some aggression process. Brain Res 1034:25-33.
20. Fujiwara S, Watanabe T, Nagatsu T, Gohda J, Imoto M, and Umezawa K (1997) Enhancement or induction of neurite formation by a protein tyrosine phosphates inhibitor, 3,4-dephostatin, in growth factor treated PC12h cells. Biochem Biophys Res Commun 238:213-217.
21. Furchgott RF and Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle cells by acetylcholine. Nature (Lond) 288:373-376.
22. Garthwaite J and Boulton CL (1995) Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57:683-706.
23. Gerling N, Culmsee C, Klumpp S, and Krieglstein J (2004) The tyrosine phosphatase inhibitor orthovanadate mimics NGF-induced neuroprotective signaling in rat hippocampal neurons. Neurochem Int 44:505-520.
24. Gidday JM, Shah AR, Maceren RG, Wang Q, Pellegrina DA, Holtzman DM, and Park TS (1999) Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab 19:331-340.
25. Gómez N and Cohen P (1991) Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature (Lond) 353:170-173.
26. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, Parada LF, and Dawson VL (2000) Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA 97:436-441.
27. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, and Ignarro LJ (1979) Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res 5:211-224.
28. Ha KS, Kim KM, Kwon YG, Bai SK, Nam WD, Yoo YM, Kim PK, Chung HT, Billiar TR, and Kim YM (2003) Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3-kinase/Akt activation. FASEB J 17:1036-1047.
29. Haendeler J, Weiland U, Zeiher AM, and Dimmeler S (1997) Effects of redox-related congeners of NO on apoptosis and caspase-3 activity. Nitric Oxide 1:282-293.
30. Haj FG, Markova B, Klaman LD, Boehmer FD, and Neel BG (2003) Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 278:739-744.
31. Hanafy KA, Krumenacker JS, and Murad F (2001) NO, nitrotyrosine and cyclic GMP in signal transduction. Med Sci Monit 7:801-819.
32. Hindley S, Juurlink BH, Gysbers JW, Middlemiss PJ, Herman MA, and Rathbone MP (1997) Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J Neurosci Res 47:427-439.
33. Hiroki A, Hatakeyama H, Kawakami M, Watanabe T, Takei I, and Umezawa K (2002) Antidiabetic effect of a nitrosamine-free dephostatin analogue, methoxime-3,4-dephostatin, in db/db mice. Biomed Pharmacother 56:179-185.
34. Holtzman DM, Kilbridge J, Bredt DS, Black SM, Li Y, Clary DO, Reichardt LF, and Mobley WC (1994) NOS induction by NGF in basal forebrain cholinergic neurones: evidence for regulation of brain NOS by a neurotrophin. Neurobiol Dis 1:51-60.
35. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, and Moskowitz MA (1996) Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 16:981-987.
36. Iadecola C, Zhang F, and Xu X (1995) Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 268:286-292.
37. Kenner KA, Anyanwu E, and Olefsky JM (1996) Kusari J. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-Istimulated signaling. J Biol Chem 271:19810-19816.
38. Kim TW, Lee CH, Choi CY, Kwon NS, Baek KJ, Kim YG, and Yun HY (2003) Nitric oxide mediates membrane depolarization-promoted survival of rat neuronal PC12 cells. Neurosci Lett 344:209-211.
39. Kim YM, Chung HT, Kim SS, Han JA, Yoo YM, Kim KM, Lee GH, Yun HY, Green A, Li J, et al. (1999) Nitric oxide protects PC12 cells from serum deprivationinduced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci 19:6740-6747.
40. Kim YM, Kim TH, Seol DW, Talanian RV, and Billiar TR (1998) Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J Biol Chem 273:31437-31441.
41. Kim YM, Talanian RV, and Billiar TR (1997) Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272:31138-31148.
42. Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dirnagl U, and Endres M (2000) Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31:2442-2449.
43. Lee SC, Zhao ML, Hirano A, and Dickson DW (1999) Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles and senile plaques. J Neuropathol Exp Neurol 58:1163-1169.
44. Li J, Billiar TR, Talanian RV, and Kim YM (1997) Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240:419-424.
45. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, and Przedborski S (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 5:1403-1409.
46. Lipton SA (1999) Neuronal protection and destruction by NO. Cell Death Differ 6:943-951.
47. Lucas HJ, Kennedy ER, and Formo MW (1995) Iodosobenzene. Org Synth Coll 3:483-485.
48. Lu X, Maysinger D, and Hagg T (2002) Tyrosine phosphatase inhibition enhances neurotrophin potency and rescues nigrostriatal neurons in adult rats. Exp Neurol 178:259-267.
49. Markova B, Herrlich P, Ronnstrand L, and Bohmer FD (2003) Identification of protein tyrosine phosphatases associating with the PDGF receptor. Biochemistry 42:2691-2699.
50. Marsh HN, Dubreuil CI, Quevedo C, Lee A, Majdan M, Walsh GS, Hausdorff S, Said FA, Zoueva O, Kozlowski M, et al. (2003) SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase. J Cell Biol 163:999-1010.
51. Monteiro HP, Gruia-Gray J, Peranovich TM, de Oliveira LC, and Stern A (2000) Nitric oxide stimulates tyrosine phosphorylation of focal adhesion kinase, Src kinase and mitogen-activated protein kinases in murine fibroblasts. Free Radic Biol Med 28:174-182.
52. Morinville A, Maysinger D, and Shaver A (1998) From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling. Trends Pharmacol Sci 19:452-460.
53. Nathan C and Shiloh MU (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 97:8841-8848.
54. Oliveira CJ, Schindler F, Ventura AM, Morais MS, Arai RJ, Debbas V, Stern A, and Monteiro HP (2003) Nitric oxide and cGMP activate the RAS-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Radic Biol Med 35:381-396.
55. Philpott KL, McCarthy MJ, Klippel A, and Rubin LL (1997) Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J Cell Biol 139:809-815.
56. Schlossmann J, Feil R, and Hofmann F (2003) Signaling through NO and cGMPdependent protein kinases. Ann Med 35:21-27.
57. Schrammel A, Behrends S, Schmidt K, Koesling D, and Mayer B (1996) Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50:1-5.
58. Shen YH, Wang XL, and Wilcken DE (1998) Nitirc oxide induces and inhibits apoptosis through different pathways. FEBS Lett 433:125-131.
59. Sofroniew MV, Howe CL, and Mobley WC (2001) Nerve growth factor signaling, neuroprotection and neural repair. Annu Rev Neurosci 24:1217-1281.
60. Suzuki T, Hiroki A, Watanabe T, Yamashita T, Takei I, and Umezawa K (2001) Potentiation of insulin-related signal transduction by a novel protein-tyrosinephosphatase inhibitor, Et-3,4 dephostatin, on cultured 3T3-L1 adipocytes. J Biol Chem 276:27511-27518.
61. Thippeswamy T and Morris R (1997) Cyclic guanosine 3′,5′- monophosphatemediated neuroprotection by nitric oxide in dissociated cultures of rat dorsal root ganglion neurones. Brain Res 774:116-122.
62. Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, and Shelanski ML (2000) Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 20:1386-1392.
63. Umezawa K, Kawakami M, and Watanabe T (2003) Molecular design and biological activities of protein-tyrosine phosphatase inhibitors. Pharmacol Ther 99:15-24.
64. Urushitani M and Shimohama S (2001) The role of nitric oxide in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2:71-81.
65. Vidwans AS, Kim S, Coffin DQ, Wink DA, and Hewett SJ (1999) Analysis of the neuroprotective effects of various nitric oxide donor compounds in murine mixed cortical cell culture. J Neurochem 72:1843-1852.
66. Vincent SR (1994) Nitric oxide: a radical neurotransmitter in the central nervous system. Prog Neurobiol 42:129-160.
67. Wendland B, Schweizer FE, Ryan TA, Nakane M, Murad F, Scheller RH, and Tsien RW (1994) Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc Natl Acad Sci USA 91:2151-2155.
68. Xia Z, Dickens M, Raingeaud J, Davis RJ, and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Wash DC) 270:1326-1331.
69. Yun H, Gonzalez-Zulueta M, Dawson VL, and Dawson TM (1998) Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21ras. Proc Natl Acad Sci USA 95:5773-5778.
70. Zhang F, Casey RM, Ross ME, and Iadecola C (1996) Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke 27:317-323.
71. Zhang ZY, Zhou B, and Xie L (2002) Modulation of protein kinase signaling by protein phosphatases and inhibitors. Pharmacol Ther 93:307-317.
72. Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, Culmsee C, Klumpp S, and Krieglstein J (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22:3898-3909.